Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 May 2;14:3203–3220. doi: 10.2147/IJN.S207589

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Ye et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

In vivo antitumor efficacy and safety evaluation of liposomes. (A) The schematic of treatment schedule. The images of excised tumors (B), body weight changes (C), tumor weight (D), and tumor growth inhibition ratio (TGI%) (E) of murine G422 glioma tumor-bearing mice after the intravenous treatment of liposomes. Each value represents the mean ± SD (n=7). *p<0.05, **p<0.01, and ***p<0.001 compared with the vehicle group.

Abbreviations: Lipo, liposomes; PEG-Lipo, PEGylated liposomes; Man-PEG-Lipo, mannosylated liposomes; TGI%, tumor growth inhibition ratio.